Unknown NA INTERVENTIONAL 2-arm NCT01069263

Comparative Study Between Hyperbaric Therapy and Intravesical Dimethyl Sulfoxide Instillation for Interstitial Cystitis

Comparison Between Hyperbaric Oxygen Therapy (HBOT) and Intravesical Dimethyl Sulfoxide (DMSO) Instillation for the Treatment of Interstitial Cystitis - a Prospective, Randomized Cross-over Trial

Sponsor: Assaf-Harofeh Medical Center

Conditions Interstitial Cystitis

Interventions DMSO Hyperbaric Oxygen Therapy

Updated 5 times since 2017 Last updated: Apr 4, 2011 Started: Feb 28, 2010 Primary completion: Mar 31, 2015 Completion: Jul 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Interstitial Cystitis and is currently ongoing. Assaf-Harofeh Medical Center leads this study, which shows 5 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Feb 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assaf-Harofeh Medical Center

Data source: Assaf-Harofeh Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zeriffin, Israel